Barbet, Jacques http://orcid.org/0000-0002-9188-984X
Funding for this research was provided by:
“Investissements d’Avenir” program (ANR-11-EQPX-0004, ANR-11-LABX-0018)
Article History
Received: 19 February 2018
Accepted: 3 March 2018
First Online: 10 March 2018
Compliance with ethical standards
:
: Jacques Barbet is a founding shareholder of Atlab Pharma SAS and OGD2 Pharma SAS, Nantes, France, companies that pursue the development of therapeutic antibodies.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study. All institutional and national guidelines for the care and use of laboratory animals were followed.